CEMB main building and landscaped gardens

About CEMB

Achievements

Transgenic cotton plants containing double gene GUSP1 and HSP70 and LTP are developed which are tolerant against heat and drought

MAJOR ACHIEVEMENTS RESEARCH AND DEVELOPMENT COMMERCIALIZATION/ INDUSTRY GRANTS / FUNDINGS PATENTS/MOUs/AGREEMENTS AND COLLABORATIONS ACADEMIA
  • 01

    Approvals for CKC-5 (triple-gene) from Punjab Seed council and CKK (five-gene) insect-resistant and weedicide-tolerant cotton variety for field trial permission from NBC

  • 02

    Salt-tolerant and drought-resistant cotton varieties have been successfully developed and subjected to field- testing

  • 03

    Developed pest resistant potato through genome editing and subjected to field evaluation

  • 04

    Developed True Potato Seed through breeding longer shelf-life potato and pest resistant

  • 05

    Discovered novel bacteriophages indigenously, that offer significant potential to combat critical health challenges such as infections caused by Multi Drug Resistant (MDR) Bacteria

  • 06

    miRNA-based Drug-Resistant genes silencing in cancer cell lines, were performed at molecular level

  • 07

    Conducted initial field trials of the larvicidal transgenic algae on the floating treatment wetlands (FTWs)

  • 08

    Assessed the immunogenicity of the Chlamydomonas reinhardtii expressed influenza CTB-M2e fusion protein in mice

  • 09

    Identified the potential therapeutic agents against Epilepsy and Parkinson’s disease and reported the four medicinal plants with potential anticancer activity

  • 10

    Genetic variations of 30 InDels markers in Azad Jammu and Kashmir Population were identified

  • 11

    Downstream process development/optimization for the process development of Filgrastim (B

  • 12

    FMDV polyepitope vaccine protein was expressed in E. coli, leading to successful antibody production

  • 13

    The compound Reserpine has been identified as a strong liver anti-fibrotic agent. The compound Reserpine ameliorated liver fibrosis by targeting the Keap1/Nrf2 pathway

  • 14

    The potential significance of targeting MALAT1 as a therapeutic strategy for breast cancer was identified

  • 15

    The compounds Betanin and Glycine Betaine downregulated expression of dengue-2 NS3 expression.

  • 16

    Coffea arabica extract was shown to have anti-inflammatory and antiarthritic effect in vitro and in vivo

  • 17

    Demonstrated that Cassia Angustifolia-primed ASCs and Plantago lanceolata and Tussilago farfara-mediated human adipose-derived stem cell therapy effectively enhance burn wound healing

  • 18

    Exosome investigation for tendon injury repair is in process

  • 19

    Developed stem cell derived exosome therapy for of liver fibrosis in rat models

  • 20

    Developed chitosan-sodium percarbonate-based hydrogels with sustained oxygen release, angiogenic and wound healing properties

  • 21

    Identification of potent senolytic drugs capable of eliminating senescent cells in in vitro diabetic cellular model

  • 22

    Clinical trials investigating the efficacy of ASCs supplemented with platelet rich plasma for diabetic foot ulcer patients in collaboration with JBRSC, Lahore, are ongoing with promising therapeutic outcomes

  • 23

    Clinical trials for Osteoarthritis and spinal cord injury patients are ongoing

  • 24

    Novel Variants identified in NAV3 gene, a neuronal morphogenesis protein, cause intellectual disability, developmental delay, and microcephaly

  • 25

    Set up commercial facilities for DNA testing, Qubit quantification and cost-effective BRCA1/2 screening for cancers

  • 26

    A three-gene cotton variety CEMB-AAS3 was recommended by the Varietal Evaluation Committee, PCCC

  • 27

    Conducted pharmacokinetics and drug toxicity studies of Semaglutide for the biopharmaceutical industry, valued at PKR 1.6 million

  • 28

    Produced PCR Enzymes and kits for in-house use, worth PKR 4.6 million

  • 29

    Revived Molecular diagnostics laboratory for hepatitis testing

  • 30

    Four TDF projects: PKR 46 million; twenty-six PU Projects: PKR 5.8 million; a CPEC project: PKR 12.963 million; 1 WHO project (AP24-01787): PKR 2.5 million

  • 31

    Ongoing: European Foundation: €125,000; Islamic Development Bank: 38.36 million PKR; Turkiye industrial: USD 25,000

  • 32

    Agreements and several collaborations with different institutions at National & International levels

  • 33

    Produced 48 M.Phil and 12 Ph.Ds. Published 89 Research Articles (impact factor of 261.614), 10 Book Chapters.

  • 34

    CEMB organized 28 conferences/scientific events, faculty and students actively participated in national and international conferences, symposia, seminars and training workshops.

  • 35

    CEMB provided internships to 53 students from institutions all over Pakistan.

Connect with CEMB

Need more information?

Contact the right team